Legend Biotech Corporation
LEGN
Xếp hạng trong cổ phiếu
#4412
Legend Biotech Corporation, through its subsidiaries, operates as a... Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
Giá cổ phiếu
$18.77
Vốn hóa thị trường
$3.47B
Thay đổi (1 ngày)
0.76%
Thay đổi (1 năm)
-41.54%
Quốc gia
US
Giao dịch Legend Biotech Corporation (LEGN)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Legend Biotech Corporation (LEGN)
Giá đóng cửa cao nhất: $18.74 vào 2026-10-01
Giá đóng cửa thấp nhất: $39.07 vào 2020-06-01
Giá đóng cửa thấp nhất: $39.07 vào 2020-06-01
Lịch sử giá cổ phiếu của Legend Biotech Corporation từ 2020 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2026 (TTM) | -1.71% |
| 2025 | -35.12% |
| 2024 | -39.91% |
| 2023 | 18.74% |
| 2022 | 6.61% |
| 2021 | 59.18% |
| 2020 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $536.98 | 25.92% |
US
|
|
| $224.77 | 737.11% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $876.75 | 7.69% |
NL
|
